PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PRCT vs. AI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PRCT and AI is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

PRCT vs. AI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in PROCEPT BioRobotics Corporation (PRCT) and C3.ai, Inc. (AI). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
19.18%
46.11%
PRCT
AI

Key characteristics

Sharpe Ratio

PRCT:

0.82

AI:

0.56

Sortino Ratio

PRCT:

1.91

AI:

1.40

Omega Ratio

PRCT:

1.22

AI:

1.17

Calmar Ratio

PRCT:

1.64

AI:

0.41

Martin Ratio

PRCT:

4.76

AI:

1.35

Ulcer Index

PRCT:

10.71%

AI:

27.16%

Daily Std Dev

PRCT:

62.36%

AI:

65.98%

Max Drawdown

PRCT:

-63.51%

AI:

-94.22%

Current Drawdown

PRCT:

-28.01%

AI:

-80.73%

Fundamentals

Market Cap

PRCT:

$3.87B

AI:

$4.36B

EPS

PRCT:

-$1.96

AI:

-$2.39

Total Revenue (TTM)

PRCT:

$156.26M

AI:

$268.14M

Gross Profit (TTM)

PRCT:

$92.16M

AI:

$161.62M

EBITDA (TTM)

PRCT:

-$65.56M

AI:

-$222.14M

Returns By Period

In the year-to-date period, PRCT achieves a -11.09% return, which is significantly lower than AI's -0.70% return.


PRCT

YTD

-11.09%

1M

-15.08%

6M

18.17%

1Y

48.47%

5Y*

N/A

10Y*

N/A

AI

YTD

-0.70%

1M

-7.42%

6M

46.11%

1Y

31.45%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PRCT vs. AI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PRCT
The Risk-Adjusted Performance Rank of PRCT is 7979
Overall Rank
The Sharpe Ratio Rank of PRCT is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of PRCT is 7979
Sortino Ratio Rank
The Omega Ratio Rank of PRCT is 7474
Omega Ratio Rank
The Calmar Ratio Rank of PRCT is 8787
Calmar Ratio Rank
The Martin Ratio Rank of PRCT is 8080
Martin Ratio Rank

AI
The Risk-Adjusted Performance Rank of AI is 6666
Overall Rank
The Sharpe Ratio Rank of AI is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of AI is 6969
Sortino Ratio Rank
The Omega Ratio Rank of AI is 6666
Omega Ratio Rank
The Calmar Ratio Rank of AI is 6565
Calmar Ratio Rank
The Martin Ratio Rank of AI is 6262
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PRCT vs. AI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and C3.ai, Inc. (AI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PRCT, currently valued at 0.79, compared to the broader market-2.000.002.004.000.790.56
The chart of Sortino ratio for PRCT, currently valued at 1.87, compared to the broader market-4.00-2.000.002.004.001.871.40
The chart of Omega ratio for PRCT, currently valued at 1.21, compared to the broader market0.501.001.502.001.211.17
The chart of Calmar ratio for PRCT, currently valued at 1.58, compared to the broader market0.002.004.006.001.580.61
The chart of Martin ratio for PRCT, currently valued at 4.55, compared to the broader market-10.000.0010.0020.0030.004.551.35
PRCT
AI

The current PRCT Sharpe Ratio is 0.82, which is higher than the AI Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of PRCT and AI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.79
0.56
PRCT
AI

Dividends

PRCT vs. AI - Dividend Comparison

Neither PRCT nor AI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PRCT vs. AI - Drawdown Comparison

The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum AI drawdown of -94.22%. Use the drawdown chart below to compare losses from any high point for PRCT and AI. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-28.01%
-32.75%
PRCT
AI

Volatility

PRCT vs. AI - Volatility Comparison

The current volatility for PROCEPT BioRobotics Corporation (PRCT) is 14.47%, while C3.ai, Inc. (AI) has a volatility of 17.01%. This indicates that PRCT experiences smaller price fluctuations and is considered to be less risky than AI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025February
14.47%
17.01%
PRCT
AI

Financials

PRCT vs. AI - Financials Comparison

This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and C3.ai, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab